Calcium ketoglutarate versus calcium acetate for treatment of hyperphosphataemia in patients on maintenance haemodialysis: A crossover study

Nephrology Dialysis Transplantation

Volumn 14, Issue 6, 1999, Pages 1475-1479

  Birck, Rainer ^a   Zimmermann, Eckhard ^b   Wassmer, Stefanie ^b   Nowack, Rainer ^a   Van Der Woude, Fokko J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Dialysis Centre   (Germany)

Author keywords

Hypercalcaemia; Phosphate binders; Renal insufficiency

Indexed keywords

2 OXOGLUTARIC ACID; CALCIUM; CALCIUM ACETATE; CALCIUM KETOGLUTARATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CROSS-OVER STUDIES; HUMANS; HYPERCALCEMIA; INFANT; KETOGLUTARIC ACIDS; MALE; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS;

EID: 0033013086     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.6.1475     Document Type: Article

References (16)

1. Ramirez JA, Emmett M, White MG et al. The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 1986; 30: 753-759
2. Delmez JA, Slatopolsky E. Hyperphosphatemia: It's consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 1992; 4: 303-317
3. Zimmermann E, Wassmer S, Steudle V. Kalziumketoglutaratein stoffwechsel-aktiver Phosphatbinder. Nieren-und Hochdruckkrankheiten 1991; 8: 371-377
4. Zimmermann E, Wassmer S, Steudle V. Long-term treatment with calcium-alpha-ketoglutarate corrects secondary hyperparathyroidism. Miner Electrolyte Metab 1996; 22: 196-199
5. Riedel E, Hampl H, Steudle V, Nuendel M. Calcium alpha-ketoglutarate administration to malnourished hemodialysis patients improves plasma arginine concentrations. Miner Electrolyte Metab 1996; 22: 119-122
6. Sheikh MS, Maguire JA, Emmett M et al. Reduction of dietary phosphorus absorption by phosphorus binders. J Clin Invest 1989; 1: 66-73
7. Mai ML, Emmett M, Sheikh MS, Santa Ana CA, Schiller L, Fordtran J. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 1989; 36: 690-695
8. Bro S, Rasmussen RA, Handberg J, Olgaard K, Feldt-Rasmussen B. Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis. Am J Kidney Dis 1998; 2: 257-262
9. Gretz N, Zimmermann E, Sellger I, Hocker A, Laserre JJ, Strauch M. Kalziumverfügbarkeit und Phosphatbindungskapazität verschiedener Kalziumsalze. Klin Wochenschr 1991; 69 [Suppl 23]: 170
10. Felig P. Amino acid metabolism in man. Ann Rev Biochem 1975; 44: 933-955
11. Kardasz S, Johnstone J, Walls J. Calcium ketoglutarate in chronic renal failure. Nephrol Dial Transpl 1996; 6 [Abstract]
12. Wernerman J, Hammarqvist F, von der Decken A, Vinnars E. Ornithine-alpha-ketoglutarate improves skeletal muscle protein synthesis as assessed by ribosome analysis and nitrogen use after surgery. Ann Surg 1987; 11: 674-678
13. Hammarqvist F, Wernerman J, von der Decken A, Vinnars E. Alpha-ketoglutarate preserves protein synthesis and free glutamine in skeletal muscle after surgery. Surgery 1991; 109: 28-36
14. Wernerman J, Hammarqvist F, Vinnars E. Alpha-ketoglutarate and postoperative muscle catabolism. Lancet 1990; 335: 701-703
15. Lowrie EG, Wei HH, Lew NL. Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison. Am J Kidney Dis 1995; 26: 220-228
16. Bergstrom J. Factors causing catabolism in maintenance hemodialysis patients. Miner Electrolyte Metab 1992; 18: 280-283